THE UNITED STATES PHARMACOPEIAL CONVENTION

Lobbying client · Maryland · filed 2025 to 2026

$610,000 Reported spend

6 Filings counted

1 Firms hired

8 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (189520), not by name.

Firms hired 1

THE UNITED STATES PHARMACOPEIAL CONVENTION $610,000 6 filings

Bills named in these filings 8

HR 4191
MAPS Act

5 filings
S 1784
MAPS Act

5 filings
HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

3 filings
S 2296
National Defense Authorization Act for Fiscal Year 2026

3 filings
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

3 filings
HR 4779
National Security, Department of State, and Related Programs Appropriations Act, 2026

2 filings
S 3788
CLEAR LABELS Act

2 filings
HR 8800
National Defense Authorization Act for Fiscal Year 2027

1 filing

Reported by year 2 years

2026 $250,000 2 filings
2025 $360,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

HOUSE OF REPRESENTATIVES 6
SENATE 6
Centers For Medicare and Medicaid Services (CMS) 1
White House Office 1

Recent filings 7 total

1A

THE UNITED STATES PHARMACOPEIAL CONVENTION

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $130,000 expenses · posted Jul 20, 2026

View → Q2

THE UNITED STATES PHARMACOPEIAL CONVENTION

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $120,000 expenses · posted Jul 20, 2026

View → Q1

THE UNITED STATES PHARMACOPEIAL CONVENTION Amended

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $110,000 expenses · posted Apr 20, 2026

View → Q4

THE UNITED STATES PHARMACOPEIAL CONVENTION

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $100,000 expenses · posted Jan 20, 2026

View → Q3

THE UNITED STATES PHARMACOPEIAL CONVENTION

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $80,000 expenses · posted Oct 20, 2025

View → Q2

THE UNITED STATES PHARMACOPEIAL CONVENTION

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $110,000 expenses · posted Jul 21, 2025

View → Q1

THE UNITED STATES PHARMACOPEIAL CONVENTION

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $70,000 expenses · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.